Frank Bedu - Jan 19, 2022 Form 4 Insider Report for PDS Biotechnology Corp (PDSB)

Role
President/CEO, Director
Signature
/s/ Frank Bedu-Addo
Stock symbol
PDSB
Transactions as of
Jan 19, 2022
Transactions value $
$0
Form type
4
Date filed
1/20/2022, 03:05 PM
Previous filing
Jun 17, 2021
Next filing
Dec 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PDSB Stock Option (Right to Buy) Award $0 -292K -50% $0.00 292K Jan 19, 2022 Common Stock 292K $6.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option, representing a right to purchase a total of 291,500 shares of Common Stock, will become exercisable on January 19, 2023, with 25% vesting on that date and the remaining vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 19, 2026.